Wahl Bryan bought TARS
March 15, 2026 · Form 4 insider transaction
Wahl Bryan bought 24,236 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,236
Price
N/A
Total value
N/A
InsiderWahl Bryan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 15, 2026
Filing dateMarch 17, 2026
Shares owned after76,399
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").; Includes 451 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.